Abbott Whistleblower Seeks New Trial In $219M Stent Row

By Y. Peter Kang · May 6, 2016, 10:49 PM EDT

The whistleblower who accused Abbott Laboratories of improperly marketing bile duct stents for off-label use asked a Texas federal judge Friday to grant a new trial after a jury in April...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Brief/Memorandum In Support

Case Information

Case Title

USA v. Abbott Laboratories et al

Case Number

Court

Texas Northern

Nature of Suit

Other Statutes: Other Statutory Actions

Date Filed

September 26, 2006

Recent Articles By Y.

November 22, 2024
Texas Justices Say Court Bungled Ruling In Abortion Case
November 21, 2024
Texas Doctor Gets 190 Years For Poisoning IV Bags
September 23, 2024
Med Mal Case Is Settled After Scuttled $111M Verdict in Minn.
September 20, 2024
Arbitration Unlikely For Nursing Home Poison Death Suit
September 19, 2024
Ill. Justices Affirm $2.1M Verdict In Blood Clot Death Suit
September 09, 2024
Texas High Court To Mull Medical Nonprofit's Med Mal Liability
September 06, 2024
NJ Atty's Med Mal, Defamation Suit Against Hospital Revived
September 05, 2024
Ohio Justices Craft New Jury Rule For Negligence Trials
August 30, 2024
Pa. Court Affirms Ex-Eagle's $43.5M Knee Injury Verdict
August 23, 2024
Matthew Perry Death Suit Could Blow Past Calif. Damage Cap